LaFrence Andrew D.C. 4/A
4/A · Vyant Bio, Inc. · Filed Jul 13, 2021
Insider Transaction Report
Form 4/AAmended
Vyant Bio, Inc.VYNT
LaFrence Andrew D.C.
Chief Financial Officer
Transactions
- Other
Common Stock, $0.0001 par value
2021-03-30+26,825→ 26,825 total(indirect: By Trust) - Other
Common Stock, $0.0001 par value
2021-03-30+29,292→ 29,292 total
Footnotes (1)
- [F1]This amended Form 4 is being filed to correct the number of shares of the Issuer's common stock, $0.0001 par value (the "Common Stock") issued pursuant to the merger on March 30, 2021.